Clinical Trials Browser

Phase 2/3 × Unknown × exemestane × Clear all

NCT05253066 2022-02-23

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

Phase 2/3 Unknown

Breast Neoplasms

NCT01648608 2012-08-03

Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast Cancer

Phase 2/3 Unknown

Breast Neoplasms